296 related articles for article (PubMed ID: 25987214)
1. The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.
Bekki K; Vogel H; Li W; Ito T; Sweeney C; Haarmann-Stemmann T; Matsumura F; Vogel CF
Pestic Biochem Physiol; 2015 May; 120():5-13. PubMed ID: 25987214
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation.
Vogel CF; Wu D; Goth SR; Baek J; Lollies A; Domhardt R; Grindel A; Pessah IN
Immunol Cell Biol; 2013 Oct; 91(9):568-75. PubMed ID: 23999131
[TBL] [Abstract][Full Text] [Related]
3. Role of NF-kB RelB in Aryl Hydrocarbon Receptor-Mediated Ligand Specific Effects.
Ishihara Y; Kado SY; Hoeper C; Harel S; Vogel CFA
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151139
[TBL] [Abstract][Full Text] [Related]
4. Interplay between Estrogen, Kynurenine, and AHR Pathways: An immunosuppressive axis with therapeutic potential for breast cancer treatment.
Pacheco JHL; Elizondo G
Biochem Pharmacol; 2023 Nov; 217():115804. PubMed ID: 37716620
[TBL] [Abstract][Full Text] [Related]
5. Suppression of acute graft-versus-host response by TCDD is independent of the CTLA-4-IFN-γ-IDO pathway.
Rohlman D; Punj S; Pennington J; Bradford S; Kerkvliet NI
Toxicol Sci; 2013 Sep; 135(1):81-90. PubMed ID: 23798565
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner.
Li F; Zhao Z; Zhang Z; Zhang Y; Guan W
BMC Cancer; 2021 Oct; 21(1):1112. PubMed ID: 34657603
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol and 3,3'-Diindolylmethane Differentially Regulate Aryl Hydrocarbon Receptor and Estrogen Receptor Alpha Activity through Multiple Transcriptomic Targets in MCF-7 Human Breast Cancer Cells.
Das S; Somisetty VS; Ulven SM; Matthews J
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834026
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine attenuates mitochondrial depolarization and neuronal cell death induced by rotenone exposure independently of AhR-mediated parkin induction in SH-SY5Y differentiated cells.
García-Aguilar R; Ortega A; López-Bayghen E; Ramírez-Martínez L; Rodriguez-Campuzano A; Murillo-González F; Elizondo G; Vega L
Neurotoxicology; 2023 Dec; 99():282-291. PubMed ID: 37979659
[TBL] [Abstract][Full Text] [Related]
9. Proteomic insight towards key modulating proteins regulated by the aryl hydrocarbon receptor involved in ovarian carcinogenesis and chemoresistance.
Therachiyil L; Peerapen P; Younis SM; Ahmad A; Thongboonkerd V; Uddin S; Korashy HM
J Proteomics; 2024 Mar; 295():105108. PubMed ID: 38316181
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development.
Vogel CFA; Lazennec G; Kado SY; Dahlem C; He Y; Castaneda A; Ishihara Y; Vogeley C; Rossi A; Haarmann-Stemmann T; Jugan J; Mori H; Borowsky AD; La Merrill MA; Sweeney C
Front Immunol; 2021; 12():625346. PubMed ID: 33763068
[TBL] [Abstract][Full Text] [Related]
11. Murine Coronavirus Infection Activates the Aryl Hydrocarbon Receptor in an Indoleamine 2,3-Dioxygenase-Independent Manner, Contributing to Cytokine Modulation and Proviral TCDD-Inducible-PARP Expression.
Grunewald ME; Shaban MG; Mackin SR; Fehr AR; Perlman S
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694960
[TBL] [Abstract][Full Text] [Related]
12. Targeting of neuroblastoma cells through Kynurenine-AHR pathway inhibition.
Dos Santos IL; Mitchell M; Nogueira PAS; Lafita-Navarro MC; Perez-Castro L; Eriom J; Kilgore JA; Williams NS; Guo L; Xu L; Conacci-Sorrell M
FEBS J; 2024 May; 291(10):2172-2190. PubMed ID: 38431776
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine, a Tryptophan Metabolite That Increases with Age, Induces Muscle Atrophy and Lipid Peroxidation.
Kaiser H; Yu K; Pandya C; Mendhe B; Isales CM; McGee-Lawrence ME; Johnson M; Fulzele S; Hamrick MW
Oxid Med Cell Longev; 2019; 2019():9894238. PubMed ID: 31737181
[TBL] [Abstract][Full Text] [Related]
14. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and kynurenine induce Parkin expression in neuroblastoma cells through different signaling pathways mediated by the aryl hydrocarbon receptor.
Murillo-González FE; García-Aguilar R; Limón-Pacheco J; Cabañas-Cortés MA; Elizondo G
Toxicol Lett; 2024 Apr; 394():114-127. PubMed ID: 38437907
[TBL] [Abstract][Full Text] [Related]
15. IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells
Amobi-McCloud A; Muthuswamy R; Battaglia S; Yu H; Liu T; Wang J; Putluri V; Singh PK; Qian F; Huang RY; Putluri N; Tsuji T; Lugade AA; Liu S; Odunsi K
Front Immunol; 2021; 12():678999. PubMed ID: 34025677
[TBL] [Abstract][Full Text] [Related]
16. Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event?
Ray S; Swanson HI
Biochem Pharmacol; 2009 Feb; 77(4):681-8. PubMed ID: 19100242
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Mechanistic Characterization of a Select Modulator of AhR-regulated Transcription (SMAhRT) with Anti-cancer Effects.
O'Donnell EF; Jang HS; Liefwalker DF; Kerkvliet NI; Kolluri SK
Apoptosis; 2021 Jun; 26(5-6):307-322. PubMed ID: 33893898
[TBL] [Abstract][Full Text] [Related]
18. Activation of the aryl hydrocarbon receptor by TCDD inhibits mammary tumor metastasis in a syngeneic mouse model of breast cancer.
Wang T; Wyrick KL; Meadows GG; Wills TB; Vorderstrasse BA
Toxicol Sci; 2011 Dec; 124(2):291-8. PubMed ID: 21948867
[TBL] [Abstract][Full Text] [Related]
19. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
Hall JM; Barhoover MA; Kazmin D; McDonnell DP; Greenlee WF; Thomas RS
Mol Endocrinol; 2010 Feb; 24(2):359-69. PubMed ID: 20032195
[TBL] [Abstract][Full Text] [Related]
20. Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy.
Kober C; Roewe J; Schmees N; Roese L; Roehn U; Bader B; Stoeckigt D; Prinz F; Gorjánácz M; Roider HG; Olesch C; Leder G; Irlbacher H; Lesche R; Lefranc J; Oezcan-Wahlbrink M; Batra AS; Elmadany N; Carretero R; Sahm K; Oezen I; Cichon F; Baumann D; Sadik A; Opitz CA; Weinmann H; Hartung IV; Kreft B; Offringa R; Platten M; Gutcher I
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37963637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
